Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
With widespread global COVID-19 vaccine coverage, a scalable, cost-effective, and standardized tool to ascertain post-vaccine immunity is a dire need. Neither clinical evaluations of vaccine efficacy, nor live virus antibody neutralization assays fulfill these criteria. Commercially available anti-S...
Main Authors: | Javeria Aijaz, Fatima Kanani, Fouzia Naseer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Journal of Clinical Virology Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667038023000042 |
Similar Items
-
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
by: Noemi Castelletti, et al.
Published: (2024-04-01) -
Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
by: Dinesh Mohanraj, et al.
Published: (2021-11-01) -
Kevin Roche : architecture as environment /
by: 443070 Pelkonen, Eeva-Liisa, et al.
Published: (c201) -
Analytical performance verification of a high throughput system for Hepatitis B and Hepatitis C viral load quantifications
by: Javeria Aijaz, et al.
Published: (2023-08-01) -
AMHconverter: an online tool for converting results between the different anti-Müllerian hormone assays of Roche Elecsys®, Beckman Access, and Kangrun
by: Huiyu Xu, et al.
Published: (2023-06-01)